- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/487 - Physical analysis of biological material of liquid biological material
Patent holdings for IPC class G01N 33/487
Total number of patents in this class: 5271
10-year publication summary
410
|
526
|
541
|
475
|
457
|
442
|
378
|
329
|
286
|
64
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Roche Sequencing Solutions, Inc. | 617 |
204 |
F. Hoffmann-La Roche AG | 7884 |
203 |
Roche Diagnostics GmbH | 2695 |
136 |
Oxford NanoPore Technologies plc | 295 |
96 |
The Regents of the University of California | 19612 |
91 |
Ascensia Diabetes Care Holdings AG | 597 |
80 |
Roche Diabetes Care, Inc. | 1504 |
74 |
Abbott Diabetes Care Inc. | 1922 |
73 |
Oxford NanoPore Technologies Limited | 274 |
72 |
Bayer HealthCare LLC | 1364 |
69 |
President and Fellows of Harvard College | 5897 |
54 |
Illumina, Inc. | 3164 |
50 |
Siemens Healthcare Diagnostics Inc. | 2015 |
47 |
Arizona Board of Regents on behalf of Arizona State University | 2516 |
42 |
PHC Holdings Corporation | 715 |
42 |
Roche Diagnostics Operations, Inc. | 1446 |
40 |
International Business Machines Corporation | 60408 |
38 |
LifeScan Scotland Limited | 112 |
30 |
The Trustees of Columbia University in the City of New York | 3533 |
26 |
AgaMatrix, Inc. | 128 |
26 |
Other owners | 3778 |